What is Matthew Buckhalter’s Aveanna Healthcare (AVAH) share ownership after these transactions?

After the reported transactions, Aveanna Healthcare’s CFO directly owned 565,273 shares of common stock. This total reflects the added shares from vested performance-based restricted stock units and the new stock-settled restricted stock unit grant reported in the Form 4 filing.

Aveanna CFO receives stock awards in Form 4

Aveanna Healthcare Holdings Chief Financial Officer Matthew Buckhalter reported equity awards in company stock.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Aveanna Healthcare Holdings Chief Financial Officer Matthew Buckhalter reported equity awards in company stock. On February 14, 2026, he acquired 15,213 shares of common stock upon vesting of performance-based restricted stock units from the company’s 2022 long-term incentive awards and 46,875 shares upon vesting of performance-based restricted stock units from 2023 long-term incentive awards, both at a price of $0 per share.

He also received a grant of 66,205 stock-settled restricted stock units subject to three-year cliff vesting. Following these award-related acquisitions, he directly owned 565,273 shares of Aveanna Healthcare common stock.

Insider Trade Summary

Grant/Award: 128,293 shares

Grant/Award 3 txns

Insider Buckhalter Matthew

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	15,213	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	46,875	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	66,205	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 565,273 shares (Direct)

Footnotes (3)

F1. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2022 long-term incentive awards.
F2. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2023 long-term incentive awards.
F3. Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Aveanna Healthcare (AVAH) disclose in this Form 4 filing?

Aveanna Healthcare reported that its CFO, Matthew Buckhalter, acquired company stock through equity awards. The filing details vesting of performance-based restricted stock units from 2022 and 2023 incentive plans and a new restricted stock unit grant, all settled in common shares at no cash cost.

How many Aveanna Healthcare (AVAH) shares did the CFO acquire on February 14, 2026?

On February 14, 2026, the CFO acquired 15,213 shares from 2022 performance-based units, 46,875 shares from 2023 performance-based units, and a grant of 66,205 stock-settled restricted stock units. These transactions were all recorded at a price of $0 per share as equity compensation.

Were Aveanna Healthcare (AVAH) shares in this Form 4 bought on the open market?

No, the shares were not bought on the open market. They were acquired through equity compensation: vesting of performance-based restricted stock units from 2022 and 2023 incentive awards, plus a new stock-settled restricted stock unit grant with three-year cliff vesting.

What do the performance-based restricted stock units mean for Aveanna Healthcare (AVAH) executives?

The performance-based restricted stock units represent incentive awards that convert into shares when performance conditions are met. For the CFO, units from 2022 and 2023 long-term incentive awards vested and were settled in common stock, aligning part of his compensation with company performance.

What are the terms of the new restricted stock unit grant at Aveanna Healthcare (AVAH)?

The new award is a grant of 66,205 stock-settled restricted stock units subject to three-year cliff vesting. Cliff vesting means the units vest all at once after three years, rather than gradually over time, and will be settled in Aveanna Healthcare common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/17/2026 - 05:30 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buckhalter Matthew

(Last)

(First)

(Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA

30339

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	02/14/2026		A		15,213⁽¹⁾	A	$0	452,193	D
Common Stock, par value $0.01 per share	02/14/2026		A		46,875⁽²⁾	A	$0	499,068	D
Common Stock, par value $0.01 per share	02/14/2026		A		66,205⁽³⁾	A	$0	565,273	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2022 long-term incentive awards.

2. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2023 long-term incentive awards.

3. Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

	/s/ Jonathan Beckler, Attorney-in-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR